Skip to content

Cranial Electrotherapy Stimulation: Piloting a Road to PTSD Prevention in First Responders

Cranial Electrotherapy Stimulation: Piloting a Road to PTSD Prevention in First Responders

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06203717
Enrollment
13
Registered
2024-01-12
Start date
2024-04-29
Completion date
2025-06-03
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults, Firefighters

Keywords

Firefighters

Brief summary

The goal of this study is to test whether active duty firefighters find it possible and suitable to do cranial electrotherapy stimulation (CES) at home, and test whether CES influences measures of depression and posttraumatic stress. The main questions it aims to answer are: * is CES feasible and acceptable in a population of firefighters, and * does CES changes symptoms of posttraumatic stress and depression as well as feelings of anxiety, and fatigue in firefighters. Participants will * complete four weeks of CES at home, and * complete daily assessments of affect and fatigue, and * complete self-reported symptoms of depression and posttraumatic stress before and after four weeks of CES at home Participants maybe asked to * complete an MRI scan before and after four weeks of CES at, and * wear a device to measure their heart rate and sleep quality.

Detailed description

Despite an urgent need for interventions that can prevent the development of posttraumatic stress disorder (PTSD) in firefighter first responders who, due to the nature of their occupation, are at ultrahigh risk for PTSD and its profound consequences, current preventative approaches suffer from low rates of efficacy or difficulties with implementation. Cranial electrotherapy stimulation (CES), a noninvasive brain stimulation technique that is FDA approved for treatment of anxiety, insomnia, and depression, offers substantial promise as a proactive preventative intervention for PTSD because of its hypothesized ability to reestablish homeostasis, a process that becomes dysregulated in individuals who develop PTSD. The proposed study is an administrative supplement that combines the unique strengths and knowledge of a complimentary team of scientists from two distinct Centers of Biomedical Research Excellence to test whether four weeks of CES is feasible and acceptable in firefighters as well as obtain early signal of CES efficacy to change subjective and objective indices of homeostatic functioning to allow a long-term collaboration with the ultimate goal to develop a safe, effective, and easily deployable intervention to prevent PTSD in first responders.

Interventions

DEVICEAlpha-Stim AID cranial electrotherapy stimulation

Cranial electrotherapy stimulation using a modified square, bipolar waveform of 0.5 Hz at 100 μA to be used for four weeks on off-duty days.

Sponsors

Butler Hospital
Lead SponsorOTHER
University of Rhode Island
CollaboratorOTHER
Brown University
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 56 Years
Healthy volunteers
Yes

Inclusion criteria

* Active duty firefighter in Rhode Island, USA; * Age between 18 and 56 years old; * Be in good medical health or, if having chronic medical conditions, these conditions needed to be stable; * Ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent.

Exclusion criteria

* MRI and CES-related contraindications, e.g., implanted metallic device or substances including pacemakers, cochlear implant, metallic tattoos, claustrophobia, pregnancy or planning to become pregnant during the study duration and nursing; * Neurological conditions such as brain neoplasm, cerebrovascular events, epilepsy or history of seizures, dementia, and neurodegenerative disorders, or had previously received brain surgery; * Report presence of suicidal ideation on QuickSCID-5 or has attempted suicide one or more times within the past twelve months; * Exhibiting a psychiatric condition that would require inpatient or partial psychiatric hospitalization; * Current moderate or severe alcohol or other substance abuse (excluding nicotine); * Major or unstable medical illness requiring further investigation or treatment.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Cranial Electrotherapy StimulationDuring four weeks of cranial electrotherapy stimulation at-home useFeasibility assessed by number of completed cranial electrotherapy stimulation sessions over the course of four weeks (feasible is defined as more than 75% of sessions completed).
Acceptability of Cranial Electrotherapy StimulationDuring four weeks of cranial electrotherapy stimulationAcceptability assessed by number of individuals who complete at least 75% of all cranial electrotherapy stimulation sessions during four weeks

Secondary

MeasureTime frameDescription
Severity of Symptoms of Posttraumatic Stress Disorder as Measured With the PTSD Checklist for DMS 5 (PCL-5)Post four weeks of cranial electrotherapy stimulationScore on the PTSD Checklist for DSM-5 (PCL-5). Scale ranges from 0 to 80 with higher scores indicating greater severity of posttraumatic stress disorder symptoms.
Severity of Symptoms of Depression as Measured With the Inventory of Depressive Symptomatology-Self Report (IDS-SR)post four weeks of cranial electrotherapy stimulation.Score on the Inventory of Depressive Symptomatology-Self Report (IDS-SR). The Inventory of Depressive Symptomatology-Self Report (IDS-SR) has a total score range of 0 to 84, with each of its 30 items rated on a scale from 0 to 3. Scores of 18 or above on the IDS-SR indicate the presence of clinically relevant depressive symptomatology.
Intensity of Feelings of FatigueAssessed daily throughout four weeks of cranial electrotherapy stimulation, day 28 reportedIntensity of subjective fatigue assessed once daily using a visual analog scale (VAS) with a 0 (not at all) - 100 (severe) scale.
Intensity of Feelings of AnxietyAssessed daily throughout four weeks of cranial electrotherapy stimulation, day 28 reportedIntensity of subjective anxiety assessed once daily using a visual analog scale (VAS) with a 0 (not at all) - 100 (severe) scale.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMascha van 't Wout-Frank, PhD

Butler Hospital

Participant flow

Participants by arm

ArmCount
Alpha-Stim AID cranial electrotherapy stimulation
Four-week course of noninvasive cranial electrotherapy stimulation. Alpha-Stim AID cranial electrotherapy stimulation: Cranial electrotherapy stimulation using a modified square, bipolar waveform of 0.5 Hz at 100 μA to be used for four weeks on off-duty days.
13
Total13

Baseline characteristics

CharacteristicAlpha-Stim AID cranial electrotherapy stimulation
Age, Continuous37.15 years
STANDARD_DEVIATION 11.07
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Intensity of Feelings of Anxiety19.69 VAS Score
STANDARD_DEVIATION 24.14
Intensity of Feelings of Fatigue34.23 VAS Score
STANDARD_DEVIATION 23.93
Inventory of Depressive Symptomatology-Self Report (IDS-SR).18.77 Score on IDS-SR
STANDARD_DEVIATION 11.35
Posttraumatic Stress Disorder (PTSD) Checklist for DSM-520.00 Score on PTSD Checklist for DSM-5
STANDARD_DEVIATION 17.29
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
13 Participants
Region of Enrollment
United States
13 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 13
other
Total, other adverse events
9 / 13
serious
Total, serious adverse events
0 / 13

Outcome results

Primary

Acceptability of Cranial Electrotherapy Stimulation

Acceptability assessed by number of individuals who complete at least 75% of all cranial electrotherapy stimulation sessions during four weeks

Time frame: During four weeks of cranial electrotherapy stimulation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Alpha-Stim AID cranial electrotherapy stimulationAcceptability of Cranial Electrotherapy Stimulation10 Participants
Primary

Feasibility of Cranial Electrotherapy Stimulation

Feasibility assessed by number of completed cranial electrotherapy stimulation sessions over the course of four weeks (feasible is defined as more than 75% of sessions completed).

Time frame: During four weeks of cranial electrotherapy stimulation at-home use

ArmMeasureValue (MEAN)Dispersion
Alpha-Stim AID cranial electrotherapy stimulationFeasibility of Cranial Electrotherapy Stimulation86.15 percentage of CES sessions completedStandard Deviation 16.51
Secondary

Intensity of Feelings of Anxiety

Intensity of anxiety will be assessed once daily using a visual analog scale (VAS) with a 0 (not at all) - 100 (severe) scale.

Time frame: Daily throughout four weeks of cranial electrotherapy stimulation

Secondary

Intensity of Feelings of Fatigue

Intensity of subjective fatigue assessed once daily using a visual analog scale (VAS) with a 0 (not at all) - 100 (severe) scale.

Time frame: Daily throughout four weeks of cranial electrotherapy stimulation

Secondary

Severity of Symptoms of Depression as Measured With the Inventory of Depressive Symptomatology-Self Report (IDS-SR)

Score on the Inventory of Depressive Symptomatology-Self Report (IDS-SR). The Inventory of Depressive Symptomatology-Self Report (IDS-SR) has a total score range of 0 to 84, with each of its 30 items rated on a scale from 0 to 3. Scores of 18 or above on the IDS-SR indicate the presence of clinically relevant depressive symptomatology.

Time frame: post four weeks of cranial electrotherapy stimulation.

ArmMeasureValue (MEAN)Dispersion
Alpha-Stim AID cranial electrotherapy stimulationSeverity of Symptoms of Depression as Measured With the Inventory of Depressive Symptomatology-Self Report (IDS-SR)11.00 score on Inventory of Depressive SymptomStandard Deviation 7.54
p-value: 0.000995% CI: [3.93, 11.61]Paired-sample t-test
Secondary

Severity of Symptoms of Posttraumatic Stress Disorder as Measured With the PTSD Checklist for DMS 5 (PCL-5)

Score on the PTSD Checklist for DSM-5 (PCL-5). Scale ranges from 0 to 80 with higher scores indicating greater severity of posttraumatic stress disorder symptoms.

Time frame: Post four weeks of cranial electrotherapy stimulation

ArmMeasureValue (MEAN)Dispersion
Alpha-Stim AID cranial electrotherapy stimulationSeverity of Symptoms of Posttraumatic Stress Disorder as Measured With the PTSD Checklist for DMS 5 (PCL-5)10.85 score on PTSD Checklist for DSM-5Standard Deviation 10.54
p-value: 0.00795% CI: [3.08, 15.23]Paired-sample t-test

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026